As hospital and health system CEOs work to advance key strategies in 2026 — from ambulatory investments to artificial intelligence integration — ...
In a Liv Hospital study, stem cell therapy improved heart function dramatically using MSCs and EVs, despite a blocked graft.
Despite a Trump administration push, there are few facilities offering the complex treatment in the rural areas where many ...
Reem Hospital, a leading healthcare institution known for its commitment to excellence and innovation in healthcare, proudly ...
Two treatments that can be traced back to the 1800s in their earliest forms have been updated and improved, as a growing ...
The National Information Technology Board (NITB) has reported a major expansion in digital health services under the One Patient One ID system at Pakistan ...
Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.
Genicular Artery Embolization (GAE) represents a new paradigm in treating knee osteoarthritis that had hitherto been handled ...
Hospitals are tightening policies to prevent patient bottlenecks, even if beds aren't available, according to a memo obtained by CBC News.
Artivion stock is outperforming the med-tech sector. Here's what investors need to know about the company and its potential ...
A research team from Scotland, England and Germany analysed data comparing outcomes for patients when an MSU responded to a 999 call.
AI-powered cardiac diagnostics firm HeartFlow reported a recent insider buy, as disclosed in the latest SEC filing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results